Clicky

Avidity Biosciences, Inc.(RNA) News

Date Title
Mar 4 Avidity Biosciences Announces Positive AOC 1001 Long-term Data Showing Reversal of Disease Progression in People Living with Myotonic Dystrophy Type 1 Across Multiple Endpoints; Same Key Endpoints Agreed for Phase 3 HARBOR™ Trial
Mar 1 Avidity Biosciences Full Year 2023 Earnings: Misses Expectations
Feb 29 Avidity Biosciences Honors Rare Disease Day®
Feb 29 Avidity Biosciences Announces Oversubscribed $400 Million Private Placement
Feb 28 Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Misses Revenue Estimates
Feb 28 Avidity Biosciences Inc (RNA) Reports Year-End Financials and Clinical Progress
Feb 28 Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights
Feb 27 Avidity Biosciences to Participate in Upcoming Investor Conferences
Dec 21 Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 1 The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie
Nov 30 Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More
Nov 29 Company News for Nov 29, 2023
Nov 29 Avidity (RNA) Expands Collaboration With BMY, Shares Rise